SCHEMBL2179158

SCHEMBL2179158

CCCC(=O)OCI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chloroform SCHEMBL8308657 0.91 ALDH1A1 (0.46)
SCHEMBL8680864 0.85
SCHEMBL6893576 0.83 DGKA (0.65)
SCHEMBL2181324 0.81 DGKA (0.69)
SCHEMBL2182828 0.81 DGKA (0.69)
SCHEMBL355564 0.81 DGKA (0.69)
SCHEMBL31112831 0.81 DGKA (0.69)
SCHEMBL2183449 0.81 DGKA (0.69)
SCHEMBL2217057 0.81 DGKA (0.69)
SCHEMBL2145671 0.81 DGKA (0.69)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122070276-A Prodrugs of xanomeline, prodrugs of trospium chloride and methods of using the same 人类生物科学股份有限公司 2026-05-19 CN disclosed
EP-4705289-A1 PRODRUGS OF XANOMELINE, PRODRUGS OF TROSPIUM AND METHODS OF USE THEREOF Terran Biosciences Inc. (US) 2026-03-11 EP disclosed
EP-4592276-A1 NOVEL ACYLOXYMETHYL PRODRUGS OF PSILOCIN AND RELATED 4-HYDROXYTRYPTAMINES OBTAINED BY AN EFFICIENT SYNTHETIC APPROACH Universität Heidelberg (DE) 2025-07-30 EP disclosed
US-20250066376-A1 OPIOID RECEPTOR ANTAGONIST PRODRUGS NIRSUM LABORATORIES INC (US) 2025-02-27 US disclosed
WO-2024226691-A1 PRODRUGS OF XANOMELINE, PRODRUGS OF TROSPIUM AND METHODS OF USE THEREOF TERRAN BIOSCIENCES INC. (US) 2024-10-31 WO disclosed
CN-116675650-B Lithium ion battery electrolyte additive, lithium ion battery electrolyte and lithium ion battery 蓝固(淄博)新能源科技有限公司 2023-10-31 CN disclosed
CN-116675650-A Lithium ion battery electrolyte additive, lithium ion battery electrolyte and lithium ion battery 蓝固(淄博)新能源科技有限公司 2023-09-01 CN disclosed
CN-111212824-B Directed beta-C (sp) of ketones 3 ) -H iodination and arylation 斯克利普斯研究院 2022-08-16 CN disclosed
CN-111212824-A Orientation of the ketone β -C (sp)3) -H iodination and arylation 斯克利普斯研究院 2020-05-29 CN disclosed
EP-2521711-B1 QUATERNARY AMMONIUM SALT PRODRUGS ALKERMES PHARMA IRELAND LTD (IE) 2017-08-16 EP disclosed
WO-1999051613-A1 PRODRUGS OF PHOSPHOROUS-CONTAINING PHARMACEUTICALS MEDIVIR AB (SE) 1999-10-14 WO disclosed
WO-1999041275-A1 PRODRUGS MEDIVIR AB (SE) 1999-08-19 WO disclosed
US-5843983-A Diphenylethane compounds containing a saturated heterocyclic group, their preparation, and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1998-12-01 US disclosed
EP-0790235-A1 Diaryl alkane derivatives containing an alicyclic group, their preparation and their therapeutic and prophylactic uses SANKYO COMPANY LIMITED (JP) 1997-08-20 EP disclosed
EP-0779889-A1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1997-06-25 EP disclosed
US-5607691-A IONTOPHORESIS AFFYMAX TECHNOLOGIES N.V. (GB) 1997-03-04 US disclosed
WO-1996007658-A1 PYRAZOLO[3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-03-14 WO disclosed
US-5243043-A Cephalosporin antibiotics and bactericides ROUSSEL UCLAF (FR) 1993-09-07 US disclosed
US-4992431-A Bactericides or antibiotics ROUSSELUCLAF (FR) 1991-02-12 US disclosed
US-3933808-A ANTIBIOTICS ELI LILLY AND COMPANY (US) 1976-01-20 US disclosed